36
Participants
Start Date
May 31, 2016
Primary Completion Date
May 15, 2017
Study Completion Date
October 17, 2017
TAS-205
2 groups: Low dose group, High dose group. Oral administration for 24 weeks, bis in die (BID) after meal
Placebo
1 group: Placebo group. Oral administration for 24 weeks, BID after meal
Nagoya City University Hospital, Aichi
National Hospital Organization Nagara Medical Center, Gifu
Kobe University Hospital, Hyōgo
National Hospital Organization Utano Hospital, Kyoto
Shinshu University Hospital, Nagano
National Hospital Organization Niigata National Hospital, Niigata
National Hospital Organization Toneyama National Hospital, Osaka
National Hospital Organization Higashisaitama Hospital, Saitama
Tokyo Women's Medical University Hospital, Tokyo
National Center of Neurology and Psychiatry, Tokyo
Tottori University Hospital, Tottori
Taiho Pharmaceutical Co., Ltd.
INDUSTRY